New data from the Health in Men Study raise questions about the role of testosterone supplementation in ageing men
Ageing of the “baby boomer” generation foreshadows a future shaped by demographic change, with increasing numbers of older Australians. The large, longitudinal Western Australian Health in Men Study (HIMS) is therefore timely, as it examines the endocrinology of male ageing and predictors of health in community-dwelling older men.1,2 As part of HIMS, my colleagues and I surveyed 3274 men aged 75–95 years in 2008–2009 using a questionnaire that included items on sexual activity.3 Of 2930 men who reported on the importance they attached to sex, 48.8% considered it important, and of the 2783 men who provided data on sexual activity, 30.8% had at least one sexual encounter (defined as any mutually voluntary activity with another person that involves sexual contact, whether or not intercourse or orgasm occurs4) in the previous 12 months.3 Of these older sexually active men, 56.5% were satisfied with the frequency of sex, while 43.0% would have preferred sex more frequently.3 These findings indicate that many older Australian men consider sexual activity important and desirable.
The full article is accessible to AMA members and paid subscribers. Login to read more or purchase a subscription now.
Please note: institutional and Research4Life access to the MJA is now provided through Wiley Online Library.
- 1 School of Medicine and Pharmacology, University of Western Australia, Perth, WA.
- 2 Department of Endocrinology and Diabetes, Fremantle Hospital, Fremantle, WA.
- 1. Yeap BB, Almeida OP, Hyde Z, et al. In men older than 70 years, total testosterone remains stable while free testosterone declines with age. The Health in Men Study. Eur J Endocrinol 2007; 156: 585-594.
- 2. Norman PE, Flicker L, Almeida OP, et al. Cohort profile: the Health In Men Study (HIMS). Int J Epidemiol 2009; 38: 48-52.
- 3. Hyde Z, Flicker L, Hankey GJ, et al. Prevalence of sexual activity and associated factors in men aged 75 to 95 years: a cohort study. Ann Intern Med 2010; 153: 693-702.
- 4. Lindau ST, Schumm LP, Laumann EO, et al. A study of sexuality and health among older adults in the United States. N Engl J Med 2007; 357: 762-774.
- 5. Wu FCW, Tajar A, Beynon JM, et al. Identification of late-onset hypogonadism in middle-aged and elderly men. N Engl J Med 2010; 363: 123-135.
- 6. Yeap BB, Hyde Z, Almeida OP, et al. Lower testosterone levels predict incident stroke and transient ischemic attack in older men. J Clin Endocrinol Metab 2009; 94: 2353-2359.
- 7. Yeap BB. Androgens and cardiovascular disease. Curr Opin Endocrinol Diabetes Obes 2010; 17: 269-276.
- 8. Cunningham GR, Toma SM. Clinical review: Why is androgen replacement in males controversial? J Clin Endocrinol Metab 2011; 96: 38-52.
- 9. Basaria S, Coviello AD, Travison TG, et al. Adverse events associated with testosterone administration. N Engl J Med 2010; 363: 109-122.
- 10. Bhasin S, Cunningham GR, Hayes FJ, et al. Testosterone therapy in men with androgen deficiency syndromes: an Endocrine Society clinical practice guideline. J Clin Endocrinol Metab 2010; 95: 2536-2559.